PTEN Protein Expression in Transition Zone Prostate Cancer: Loss of Expression and Correlation with TMPRSS2-ERG Rearrangement Status

被引：0
|
作者：
Gopalan, A. [1 ]
Savage, C. [1 ]
Maschino, A. [1 ]
Leversha, M. A. [1 ]
McGuire, J. [1 ]
Al-Ahmadie, H. A. [1 ]
Tickoo, S. K. [1 ]
Gerald, W. L. [1 ]
Reuter, V. E. [1 ]
Fine, S. W. [1 ]
机构：
[1] MSKCC, New York, NY USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
855
引用
收藏
页码：193A / 193A
页数：1
相关论文
共 50 条
  • [41] Relation of ETS transcription factor family member ERG, androgen receptor and topoisomerase 2β expression to TMPRSS2-ERG fusion status in prostate cancer
    Kolar, Z.
    Burdova, A.
    Jamaspishvili, T.
    Bouchal, J.
    Kucerova, R.
    Bienova, M.
    Kral, M.
    Student, V.
    NEOPLASMA, 2014, 61 (01) : 9 - 16
  • [42] Identification of potential prostate cancer biomarkers associated with TMPRSS2-ERG fusion and PTEN deletions
    Almami, Amal A.
    CANCER RESEARCH, 2012, 72
  • [43] Correlation between ERG rearrangement and PTEN loss with capsular penetration in prostate cancer
    Brosh, L.
    Abril, E.
    Cortez, C.
    Algotar, A.
    Meek, W.
    Dexter, E.
    Dittamore, R.
    Dalkin, B.
    Nagle, R.
    Pestano, G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E427 - U936
  • [44] TMPRSS2-ERG gene fusion in metastatic prostate cancer
    Guo, C.
    Cao, D.
    Navone, N.
    Efstathiou, E.
    Maity, S.
    Troncoso, P.
    Czerniak, B.
    HISTOPATHOLOGY, 2008, 53 : 277 - 277
  • [45] Delineation of TMPRSS2-ERG splice variants in prostate cancer
    Hu, Ying
    Dobi, Albert
    Sreenath, Tacluru
    Cook, Christopher
    Tadase, Atekelt Y.
    Ravindranath, Lakshmi
    Cullen, Jennifer
    Furusato, Bungo
    Chen, Yongmei
    Thangapazham, Rajesh L.
    Mohamed, Ahmed
    Sun, Chen
    Sesterhenn, Isabell A.
    McLeod, David G.
    Petrovics, Gyorgy
    Srivastava, Shiv
    CLINICAL CANCER RESEARCH, 2008, 14 (15) : 4719 - 4725
  • [46] Role of the TMPRSS2-ERG gene fusion in prostate cancer
    Chinnaiyan, Arul M.
    NEOPLASIA, 2008, 10 (02): : 177 - U23
  • [47] ASSOCIATION OF GERMLINE GENETIC VARIANTS WITH TMPRSS2-ERG FUSION STATUS IN PROSTATE CANCER
    Kohaar, Indu
    Ravindranath, Lakshmi
    Young, Denise
    Ali, Amina
    Li, Qiyuan
    Dobi, Albert
    McLeod, David
    Rosner, Inger
    Sesterhenn, Isabell
    Freedman, Matthew
    Srivastava, Shiv
    Petrovics, Gyorgy
    JOURNAL OF UROLOGY, 2017, 197 (04): : E1172 - E1173
  • [48] NY-ESO-1 Expression is Tightly Linked to TMPRSS2-ERG Fusion in Prostate Cancer
    Grupp, Katharina
    Ospina-Klinck, Daniel
    Tsourlakis, Maria Christina
    Koop, Christina
    Wilczak, Waldemar
    Adam, Meike
    Simon, Ronald
    Sauter, Guido
    Izbicki, Jakob Robert
    Graefen, Markus
    Huland, Hartwig
    Steurer, Stefan
    Schlomm, Thorsten
    Minner, Sarah
    Quaas, Alexander
    PROSTATE, 2014, 74 (10): : 1012 - 1022
  • [49] TMPRSS2-ERG rearrangement in dominant anterior prostatic tumours: incidence and correlation with ERG immunohistochemistry
    Gopalan, Anuradha
    Leversha, Margaret A.
    Dudas, Maria E.
    Maschino, Alexandra C.
    Chang, Jeremy
    Al-Ahmadie, Hikmat A.
    Chen, Ying-Bei
    Tickoo, Satish K.
    Reuter, Victor E.
    Fine, Samson W.
    HISTOPATHOLOGY, 2013, 63 (02) : 279 - 286
  • [50] TMPRSS2-ERG Fusion in an Uncommon Presentation of Prostate Cancer
    Adra, Nabil
    Cheng, Liang
    Hanna, Nasser H.
    Durm, Greg
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : E489 - E491
12345